GALT Logo

Galectin Therapeutics Inc. (GALT) 

NASDAQ
Market Cap
$137.97M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
347 of 809
Rank in Industry
212 of 445

Largest Insider Buys in Sector

GALT Stock Price History Chart

GALT Stock Performance

About Galectin Therapeutics Inc.

Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial for the treatment of liver fibrosis associated with fatty liver disease and non-alcoholic steatohepatitis cirrhosis, as well as for the treatment of cancer. It also engages in developing GM-CT-01, which is in pre-clinical development stage for the treatment of cardiac and vascular fibrosis, as well as focuses on developing belapectin for the treatment of psoriasis, and lung and kidney fibrosis. The company, through its Galectin Sciences, LLC, which is a collaborative joint venture co-owned by SBH Sciences, Inc., to research and development of small organic molecule inhibitors of galectin-3 for oral administration. The company was formerly known as Pro-Pharmaceuticals, Inc. and changed its name to Galectin Therapeutics, Inc. in May 2011. Galectin Therapeutics Inc. was founded in 2000 and is based in Norcross, Georgia.

Insider Activity of Galectin Therapeutics Inc.

Over the last 12 months, insiders at Galectin Therapeutics Inc. have bought $24,057 and sold $76,500 worth of Galectin Therapeutics Inc. stock.

On average, over the past 5 years, insiders at Galectin Therapeutics Inc. have bought $49,567 and sold $206,128 worth of stock each year.

Highest buying activity among insiders over the last 12 months: FREEMAN KEVIN D (director) — $13,400. ELDRED KARY (director) — $3,747. Zordani Richard A. Jr. (director) — $3,520.

The last purchase of 2,500 shares for transaction amount of $5,950 was made by FREEMAN KEVIN D (director) on 2024‑06‑20.

List of Insider Buy and Sell Transactions, Galectin Therapeutics Inc.

2024-06-20PurchaseFREEMAN KEVIN Ddirector
2,500
0.0037%
$2.38$5,950-7.85%
2024-04-30PurchaseZordani Richard A. Jr.director
1,000
0.0016%
$3.52$3,520-20.00%
2024-04-24PurchaseLEWIS JOELPresident and CEO
1,000
0.0016%
$3.39$3,390-10.79%
2024-04-23SaleCZIRR JAMES C10 percent owner
3,677
0.0054%
$3.06$11,252-10.36%
2024-04-22SaleCZIRR JAMES C10 percent owner
21,323
0.0344%
$3.06$65,248-0.49%
2024-04-22PurchaseFREEMAN KEVIN Ddirector
2,500
0.0039%
$2.98$7,450-0.49%
2024-01-16PurchaseELDRED KARYdirector
500
0.0008%
$1.79$893+34.07%
2023-07-19PurchaseELDRED KARYdirector
1,598
0.0028%
$1.79$2,854+14.33%
2023-02-21PurchaseELDRED KARY
1,000
0.0017%
$1.59$1,591+10.00%
2023-02-16PurchaseLEWIS JOEL
1,000
0.0017%
$1.52$1,520+17.33%
2023-01-25PurchaseELDRED KARYdirector
1,300
0.0022%
$1.11$1,443+60.00%
2022-11-17PurchaseCALLICUTT JACK WChief Financial Officer
4,000
0.0065%
$1.32$5,280+22.79%
2022-10-28PurchaseFREEMAN KEVIN Ddirector
10,000
0.0171%
$1.41$14,100+16.55%
2022-07-28PurchaseZordani Richard A. Jr.
5,000
0.0085%
$2.50$12,500-34.68%
2022-07-27Sale10X Fund, L.P.10 percent owner
10,000
0.0171%
$2.09$20,870-21.36%
2022-07-22SaleCZIRR JAMES C
10,000
0.019%
$2.09$20,870-11.89%
2022-05-19PurchaseFREEMAN KEVIN D
5,000
0.0085%
$1.33$6,650+23.48%
2022-04-18PurchaseFREEMAN KEVIN D
5,000
0.0086%
$1.71$8,550-7.74%
2022-04-04PurchaseZordani Richard A. Jr.
5,000
0.0084%
$1.60$8,025-3.73%
2022-02-02Sale10X Fund, L.P.10 percent owner
10,000
0.0163%
$2.10$21,000-27.65%

Insider Historical Profitability

3.7%
CZIRR JAMES C
5922207
9.9742%
$2.22330<0.0001%
FREEMAN KEVIN Ddirector
28469
0.1213%
$2.22260+0.09%
ELDRED KARYdirector
49313
0.0797%
$2.2260+5.2%
Zordani Richard A. Jr.
1000
0.0478%
$2.2240<0.0001%
LEWIS JOEL
2000
0.0016%
$2.2270<0.0001%
Martin Rod Ddirector
9357422
15.1295%
$2.2214<0.0001%
Uihlein Richard E
7893191
12.7621%
$2.2260<0.0001%
10X Fund, L.P.10 percent owner
6168940
9.9742%
$2.22038
FIRTEL BURTON Cdirector
129000
0.2086%
$2.2230+32.75%
ROME JERALD Kdirector
117344
0.1897%
$2.2220+11.02%
Greenberg Arthurdirector
109445
0.177%
$2.2260<0.0001%
TRABER PETER GPresident & CEO
107333
0.1735%
$2.22112+22.8%
Prelack Stevendirector
87219
0.141%
$2.2201
OMENN GILBERT Sdirector
66769
0.108%
$2.2212<0.0001%
SMITH DAVID Hdirector
63500
0.1027%
$2.2210<0.0001%
AMELIO GILBERT Fdirector
60614
0.098%
$2.2216+7.71%
CHRISTIAN MILDRED Sdirector
27500
0.0445%
$2.2210<0.0001%
CONAWAY DALE Hdirector
22806
0.0369%
$2.2240<0.0001%
MAULDIN JOHN Fdirector
18074
0.0292%
$2.22120+77.12%
CHRISTOPHER DAVID AFORMER CFO & TREASURER
16629
0.0269%
$2.2202
Rubin Marcdirector
13581
0.022%
$2.2234+24.3%
MCGAULEY THOMASChief Financial Officer
10000
0.0162%
$2.2210<0.0001%
PRESSLER HERMAN PAULdirector
9500
0.0154%
$2.2210<0.0001%
CALLICUTT JACK WChief Financial Officer
7614
0.0123%
$2.2247<0.0001%
PLATT DAVIDChairman & CEO
6000
0.0097%
$2.2231+15%
FOLEY MAUREENChief Operating Officer
5000
0.0081%
$2.2210+26.27%
Gourzis James Theophiledirector
2000
0.0032%
$2.22100%
ZUCCONI THEODORE DANIELdirector
1083
0.0018%
$2.2231+8.35%
Schwartz Elissa J.
1000
0.0016%
$2.2210<0.0001%
Shlevin Harold H.Chief Operating Officer
0
0%
$2.22110

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
The Vanguard Group$4.73M3.191.98M+1.96%+$90,908.42<0.0001
Advisor Group Holdings Inc$3.02M2.041.26M+1.1%+$32,974.500.01
BlackRock$1.7M1.15712,638-0.38%-$6,484.07<0.0001
Geode Capital Management$1.36M0.91567,161+10.25%+$126,086.24<0.0001
Geneos Wealth Management Inc$977,152.000.66408,850-0.92%-$9,082.000.05
Sontag Advisory LLC$952,114.000.64398,374+116.67%+$512,683.760.01
Susquehanna International Group$860,056.000.58359,856+354.82%+$670,959.17<0.01
Atria Wealth Solutions Inc$513,372.000.35214,800-14.01%-$83,650.000.01
Morgan Stanley$441,412.000.3184,691-0.25%-$1,089.84<0.0001
State Street$385,842.000.26161,4400%+$0<0.0001
Cambridge Investment Research Advisors Inc$290,000.000.2121,141-4.3%-$13,022.84<0.01
Cutter Co Brokerage Inc$275,947.000.19115,459-1.73%-$4,849.310.05
Northern Trust$241,751.000.16101,151+0.13%+$308.31<0.0001
Qube Research & Technologies$165,018.000.1169,045-8.44%-$15,217.17<0.0001
LINSCO PRIVATE LEDGER CORP$131,598.000.0955,062+6.27%+$7,767.49<0.0001
Horizon Kinetics LLC$128,443.000.0953,7420%+$0<0.01
Synovus$114,720.000.0848,0000%+$0<0.01
D.A. Davidson Companies$113,895.000.0847,655+11.72%+$11,949.95<0.01
Squarepoint Ops LLC$114,565.000.0847,935New+$114,565.00<0.0001
Stratos Wealth Partners$96,676.000.0740,4500%+$0<0.01
Blair William Co Il$90,543.000.0637,8840%+$0<0.0001
Jane Street Capital$87,916.000.0636,785+8.93%+$7,208.23<0.0001
Traynor Capital Management Inc$82,950.000.0634,7070%+$00.01
Retirement Guys Formula Llc$80,619.000.0533,732+56.89%+$29,234.310.04
Mariner Llc$67,823.000.0528,378+160.88%+$41,824.74<0.0001
Millennium Management LLC$59,944.000.0425,081-9.62%-$6,381.34<0.0001
Vivaldi Capital Management$72,817.000.0424,032+24.77%+$14,456.140.02
Creative Planning$57,871.000.0424,2140%+$0<0.0001
Citadel Advisors LLC$58,605.000.0424,521+249.8%+$41,851.15<0.0001
Beacon Capital Management Llc$57,133.000.0423,905New+$57,133.000.01
Summit Trail Advisors$47,800.000.0320,0000%+$0<0.01
Wealth Enhancement Advisory Services LLC$44,547.000.0318,6390%+$0<0.0001
Charles Schwab$41,617.000.0317,4130%+$0<0.0001
Wedbush Securities Inc$37,000.000.0315,4980%+$0<0.01
Bank of America$35,212.000.0214,733+161.59%+$21,751.47<0.0001
Buckingham Asset Management Llc$31,629.000.0213,2340%+$0<0.01
Dynamic Advisor Solutions Llc$29,653.000.0212,4070%+$0<0.01
Shepherd Kaplan Krochuk, LLC$28,680.000.0212,0000%+$00.03
Y Intercept Hong Kong Ltd$26,625.000.0211,140New+$26,625.00<0.01
Inspire Advisors$27,062.000.0211,3230%+$00.01
Integrated Wealth Concepts Llc$23,900.000.0210,0000%+$0<0.0001
Simplex Trading Llc$18,000.000.017,877+13.18%+$2,095.47<0.01
Wells Fargo$17,338.000.017,254-4.33%-$783.96<0.0001
Ronald Blue Trust Inc$16,730.000.017,0000%+$0<0.0001
Tower Research Capital$13,429.000.015,619-23.73%-$4,177.59<0.0001
Meeder Asset Management Inc$9,123.000.013,8170%+$0<0.01
Sound Income Strategies$7,122.000.012,9800%+$0<0.01
Clearstead Advisors Llc$9,240.000.013,0000%+$0<0.0001
JPMorgan Chase$4,472.00<0.011,871+2.63%+$114.73<0.0001
Group One Trading$1,295.00<0.01542New+$1,295.00<0.0001